Michael Conick Hanley's Insider Trades & SAST Disclosures
Michael Conick Hanley's most recent trade in Alto Neuroscience Inc. was a trade of 125,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Conick Hanley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alto Neuroscience Inc. | Michael Conick Hanley | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Michael Conick Hanley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 188,000 | 188,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 08 Jun 2022 | 28,200 | 36,200 (0%) | 0% | 0.7 | 20,022 | Common Stock |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 160,000 | 160,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 135,000 | 135,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges